Millennium Cell, Inc.
MCELQ
$0.00
$0.000.00%
| Weiss Ratings | MCELQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | -- | |||
| Risk Index | -- | |||
| Risk Grade | -- | |||
| Reward Grade | -- | |||
| Rating Factors | MCELQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | -- | |||
| Efficiency Index | -- | |||
| Solvency Index | -- | |||
| Total Return Index | -- | |||
| Volatility Index | -- | |||
| Beta / Standard Deviation | MCELQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -13.08 | |||
| Price History | MCELQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -99.90% | |||
| 52-Week High % Change | -90.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | MCELQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Mar 20, 2024 | |||
| 52-Week High Price (Date) | Apr 08, 2024 | |||
| Valuation | MCELQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 75.00 | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -- | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | MCELQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | -- | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MCELQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 732-542-4000 | |||
| Address | One Industrial Way West Eatontown, NJ 07724 | |||
| Website | www.millenniumcell.com | |||
| Country | United States | |||
| Year Founded | 1998 | |||
| Profitability | MCELQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -1,376.77% | |||
| Profit Margin | -1,331.31% | |||
| Management Effectiveness | MCELQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -57.28% | |||
| Return on Equity | -- | |||
| Income Statement | MCELQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 756.60K | |||
| Total Revenue (TTM) | 756.60K | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 6.10K | |||
| EBITDA (TTM) | -9.60M | |||
| EBIT (TTM) | -10.42M | |||
| Net Income (TTM) | -10.07M | |||
| Net Income Avl. to Common (TTM) | -10.07M | |||
| Total Revenue Growth (Q YOY) | 409.86% | |||
| Earnings Growth (Q YOY) | 44.53% | |||
| EPS Diluted (TTM) | -0.18 | |||
| EPS Diluted Growth (Q YOY) | 58.17% | |||
| Balance Sheet | MCELQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.51M | |||
| Cash Per Share (Q) | $0.05 | |||
| Total Current Assets (Q) | 4.98M | |||
| Total Preferred Equity (Q) | 4.33 | |||
| Total Equity (Q) | 5.96M | |||
| Current Ratio (Q) | 2.900 | |||
| Book Value Per Share (Q) | -- | |||
| Total Assets (Q) | -- | |||
| Total Current Liabilities (Q) | 1.72M | |||
| Total Debt (Q) | -- | |||
| Total Liabilities (Q) | -- | |||
| Total Common Equity (Q) | 1.63M | |||
| Cash Flow | MCELQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 88.60K | |||
| Cash from Financing (TTM) | 6.28M | |||
| Net Change in Cash (TTM) | -848.30K | |||
| Levered Free Cash Flow (TTM) | -4.50M | |||
| Cash from Operations (TTM) | -7.21M | |||
